AI Summary

Researchers at Boston Children’s Hospital’s FM Kirby Neurobiology Center, led by Clifford Woolf, have developed a new method to lessen chronic neuropathic pain. The approach targets pain‑sensing nerve cells called nociceptors, disrupting specific protein interactions within these cells. By interfering with these interactions, the technique aims to reduce the abnormal pain signals that drive neuropathic discomfort. The study represents a potential non‑opioid strategy for managing this difficult condition.

AI summaries can be wrong sometimes—always verify important details using the source article.